“AFP” quoted the official in US Food and Drug AdministrationStephen Hahn, as saying that “Allow these treatments With antibodies Monoclonal therapy may allow patients to avoid hospitalization and reduce the burden on our healthcare system. ”
For his part, CEO of Regeneron, Leonard Schleifer, said that this constitutes “an important step in the fight against Covid-19, as patients at high risk in the United States will be able to obtain a promising treatment early in the course of infection.”
The green light was given to treat Regeneron, called Regen-Cove-2, which is a combination of two antibodies, after it was shown to reduce Covid-19 cases that require hospitalization or emergency rooms.
The American company “Pfizer” and its German partner “BountechOn Friday, they announced that they had submitted a request to the US Food and Drug Administration to approve the emergency use of the Covid-19 vaccine.
The companies expect the Food and Drug Administration to grant approval for emergency use by mid-December.
And they said that they would start charging the doses immediately, knowing that “Pfizer“I expected to have 50 million vaccine doses ready this year, enough to protect 25 million people.
These were the details of the news In Trump’s treatment, he used a green light to use the... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at eg24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.